Insulin glargine and lixisenatide and M-End Max D
Determining the interaction of Insulin glargine and lixisenatide and M-End Max D and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: codeine / dexbrompheniramine / pseudoephedrine
Brand name: M-End Max D
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-M-End PE
- Insulin glargine and lixisenatide-M-End WC
- Insulin glargine and lixisenatide-M-Hist DM
- Insulin glargine and lixisenatide-M-Hist PD
- Insulin glargine and lixisenatide-M-M-R II
- Insulin glargine and lixisenatide-M-M-R II Vaccine
- M-End Max D-Insulin glargine and lixisenatide Subcutaneous
- M-End Max D-Insulin glargine, recombinant Subcutaneous
- M-End Max D-Insulin glulisine
- M-End Max D-Insulin Glulisine (Cartridges and Pens)
- M-End Max D-Insulin Glulisine (Vials)
- M-End Max D-Insulin glulisine Subcutaneous